GeoVax Announces Peer-Reviewed Publication

Geovax Labs

VIP LIVEALERTS-PRO GeoVax Peer-Reviewed Publication GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization ATLANTA, GA, July 28, 2022 – (VipLiveAlerts-Pro NewsWire) GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today […]